Dorothy J. Clarke

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Ernexa Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.

Get ERNA alerts

About Dorothy J. Clarke

Dorothy J. Clarke is recorded as Board Member at Ernexa Therapeutics Inc. (ERNA) since August 28, 2023. Ernexa Therapeutics Inc. reported in an 8-K filed August 31, 2023 that Dorothy J. Clarke was appointed director, effective August 28, 2023. Ernexa Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ernexa Therapeutics Inc. includes Dr. Matthew Angel (CEO), Matt Angel, Ph.D. (CEO), Sanjeev Luther (CEO and Board Member) and 7 others.

“On August 28, 2023, the Board of Directors (the "Board") of Eterna Therapeutics Inc. (the "Company") appointed Ms. Dorothy J. Clarke as a director, effective on August 28, 2023.”

Ernexa Therapeutics Inc. Form 8-K, filed August 31, 2023 · Read the filing

Affiliation history

Ernexa Therapeutics Inc. (ERNA)
Board Member

SEC 8-K

Current
2023-08-28–present

Company network

Ernexa Therapeutics Inc.

ERNA

Current role

Biotechnology · Healthcare

Board Member

2023-08-28–present

Leadership on record at Ernexa Therapeutics Inc.

Dr. Matthew Angel CEO
Matt Angel, Ph.D. CEO
Sanjeev Luther CEO, Board Member
Allen Wolff Chairman, Board Member
James Bristol Chairman
Luba Greenwood Chairman, Board Member
Sandra Gurrola CFO
Dorothy Clarke General Counsel
Brant C. Binder Board Member
Dennis H. Langer Board Member

Recent activity

Executive change Appointed: director Ernexa Therapeutics Inc. (ERNA)
2023-08-28